Ohio State University Comprehensive Cancer Center ( Site 0103) — Columbus, Ohio

Ohio State University Comprehensive Cancer Center ( Site 0103) is a clinical research site located in Columbus, Ohio, United States 43203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ohio State University Comprehensive Cancer Center ( Site 0103) has participated in 1 clinical trials.

Therapeutic areas: Polycythemia Vera.

Sponsors: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ohio State University Comprehensive Cancer Center ( Site 0103)?

Ohio State University Comprehensive Cancer Center ( Site 0103) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ohio State University Comprehensive Cancer Center ( Site 0103) conducted?

Ohio State University Comprehensive Cancer Center ( Site 0103) has 1 clinical trials on record. Their work covers Polycythemia Vera.

Is Ohio State University Comprehensive Cancer Center ( Site 0103) accredited by Crixeo Health?

Ohio State University Comprehensive Cancer Center ( Site 0103) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ohio State University Comprehensive Cancer Center ( Site 0103)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.